GRDN Guardian Pharmacy Services, Inc.
GRDN Guardian Pharmacy Services, Inc.
Healthcare · Medical Care Facilities
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $29.12 · VWAP $33.82 · +12.4% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
GRDN Price Structure
Loading timeframes…
Peers
Every watchlist GRDN belongs to, members best 30-day change first — GRDN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@monster-discoveries
Reported the quarter ending 2026-03-31: revenue $337M, net income $13M (SEC filing). Across the print the stock moved -2.6% (close before → first close after).
full note →Against street estimates
How GRDN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about GRDN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
- Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
- Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
- Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call
- Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock
- Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
GRDN research tape
17 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.